-
Uncategorized5 months ago
A microbial platform for selective biosynthesis of monoterpene esters
Post Content
-
Uncategorized5 months ago
Organ-on-Chip Integrated Into Preclinical Glioblastoma Research
Dynamic42 and EPO (Experimental Pharmacology and Oncology), both based in Germany, report that they are addressing the limited availability of preclinical models in brain cancer research...
-
Uncategorized5 months agoTeam approach to lowering high blood pressure worked even in ‘a tough landscape’
It’s the leading risk factor for the leading cause of death in the United States and around the world: high blood pressure, the prime mover in...
-
Uncategorized5 months agoSTAT+: Influential Democratic think tank pushes plan for government to lower health care costs
WASHINGTON — An influential progressive think tank is proposing that Democrats assert more federal government control over hospitals and private insurers to make health care more...
-
Uncategorized5 months agoNeuroblastoma Tumor Growth in Mice Suppressed by Blocking Enzyme to Inhibit mTOR Signaling
Neuroblastoma is the most common tumor among children under a year of age, and while in its gentlest form neuroblastoma can regress on its own, it...
-
Uncategorized5 months agoSmart contact lens monitors eye pressure and delivers glaucoma drugs in early tests
Glaucoma is the second-leading cause of blindness, and a silent one at that. It’s estimated that half of the patients who develop it are unaware of...
-
Uncategorized5 months agoSidewinder secures $137M to advance ‘precision’ ADCs
Backed by OrbiMed, Novartis’ venture arm and many other investors, the biotech is among those working on newer technology that could broaden the reach of antibody-drug...
-
Uncategorized5 months ago
PhRMA head Steve Ubl to step down, according to sources
Stephen Ubl, the leader of the drug industry’s powerful Washington, DC, lobbying group PhRMA, plans to step down, Endpoints News has learned from sources familiar with...
-
Uncategorized5 months ago
With 3 quick buyouts, Gilead leans into its latest transformation
On a conference call with analysts, Gilead walked through how a string of recent deals focused on cancer and autoimmune conditions could help a diversification plan...
-
Uncategorized5 months ago
Forecasting Protein Aggregation with an Improved Algorithm
A new, improved algorithm for studying protein aggregation could help biologics manufacturers design better-performing products with less experimental effort. The software, developed by scientists based in Barcelona,...
Generic Drugs
China plans to transform $3M biotech sector into $522B powerhouse by 2030
FDA approves imlunestrant in combination with abemaciclib for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer
Scientists turn pig semen extract into eye drops that kill cancer in mice
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
